Hyperhomocystinemia, an atherosclerotic risk factor that induces endothelial dysfunction and alters the elastic properties of the vascular wall, also inhibits LOX activity and negatively regulates endothelial LOX expression at the transcriptional level [30]. This evidence concerns the gene LOX and endothelial dysfunction.